Which hedge funds own DMAC? DIAMEDICA THERAPEUTICS INC, Q2 2026 13F holders

13 tracked hedge funds disclosed a position in DMAC (DIAMEDICA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $13.1m in total. The largest holder by portfolio weight is Bleichroeder LP at 0.5% of its book. 4 opened a new position this quarter: Diametric Capital, LP, Persistent Asset Partners Ltd, Squarepoint Ops LLC, Aquatic Capital Management LLC. 4 exited: First Manhattan, ExodusPoint Capital Management, LP, Renaissance Technologies LLC.

13

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

4

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

4

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$1.6m

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$3.9m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$13.1m

Combined value

Sum of the holders' reported positions in the security.

1.0%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.